PitchSend

Investor Presentaiton

Investor presentation Full year 2018 The GLP-1 segment accounts for around 1% of the total diabetes care market value in Region China Slide 78 Chinese GLP-1 market VictozaⓇ value market share in Region China DKK billion VictozaⓇ Exenatide GLP-1 market value Share of total diabetes care GLP-1 value Victoza® Exenatide market share market 100% 0.3 1.5% 87% CAGR value¹: 33.6% 80% 0.2 1.0% 60% 0.1 0.0 Nov 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Nov, 2018 value figures changing diabetes 40% 0.5% 20% 0.0% 0% Nov 2018 Nov 2013 Source: IQVIA monthly MAT Nov, 2018 value figures. Market share does not add up to 100% due to rounding Nov 2018 12% novo nordisk

View entire presentation